Search

everythinglearnresearchcommunity

for

Search:↓

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

AC-5216 reduces anxiety in mice through neurosteroids affecting GABAA receptors.

Perhexiline can effectively target ovarian cancer cells left after treatment.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Certain existing drugs, like glycopyrronium and botulinum toxin type A, may help treat excessive sweating.

New anti-acne medications are being tested to offer alternatives to current treatments.

Suppressing ODC activity reduces tumor growth in hair follicles.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

The model successfully predicted new uses for existing drugs, like using certain hormonal and heart medications for respiratory and Parkinson's diseases, and a cancer drug for diabetes.

HS patients rarely see dermatologists, often get opiates, and need better care.

Pramipexole can cause side effects like dizziness, sleepiness, hallucinations, and low blood pressure, and it's important to educate patients and keep doses low.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

Environmental factors can greatly reduce drug levels in hair.

Chronic obstructive pulmonary disease (COPD) is managed with personalized medication to ease symptoms and improve life quality.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Pill organizers and cutters can help with taking medication regularly but may affect the medication's effectiveness and safety.

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

Finasteride reduces pain in male rats and works better with testosterone.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.